A summary of the world-wide clinical investigations of recombinant factor VIII.
Schwartz
R S
RS
Cutter Biological, Miles Inc., Berkeley, CA 94701.
Rousell
R H
RH
D004341:Drug Evaluation; D005060:Europe; D005169:Factor VIII / Q000009:adverse effects / Q000627:therapeutic use*; D006467:Hemophilia A / Q000628:therapy*; D006801:Humans; D007564:Japan; D009656:North America; D011993:Recombinant Fusion Proteins / Q000009:adverse effects / Q000627:therapeutic use*
D011993:Recombinant Fusion Proteins; D005169:Factor VIII